Oncology and Hematology - Global Oncology Academy

497-512 of 651

Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Project Oncology®
Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Addressing Health Equity in Genitourinary Cancer Clinical Trials
Addressing Health Equity in Genitourinary Cancer Clinical Trials
Project Oncology®
Addressing Health Equity in Genitourinary Cancer Clinical Trials
An Exploration of Current and Emerging Therapies for mCRPC
An Exploration of Current and Emerging Therapies for mCRPC
Project Oncology®
An Exploration of Current and Emerging Therapies for mCRPC
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Project Oncology®
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Jacob Sands, MD; Liza Villaruz, MD
- Jacob Sands, MD
- Liza Villaruz, MD
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
Project Oncology®
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
Filipa Lynce, MD
- Filipa Lynce, MD
Inflammatory Breast Cancer: A New Scoring System Proposed
Inflammatory Breast Cancer: A New Scoring System Proposed
Project Oncology®
Inflammatory Breast Cancer: A New Scoring System Proposed
Filipa Lynce, MD
- Filipa Lynce, MD
A Look at What’s New in Invasive Lobular Carcinoma
A Look at What’s New in Invasive Lobular Carcinoma
Project Oncology®
A Look at What’s New in Invasive Lobular Carcinoma
Pavani Chalasani, MD, MPH; Jason A. Mouabbi, MD
- Pavani Chalasani, MD, MPH
- Jason A. Mouabbi, MD
The Evolving Landscape of Targeted Therapies for Non-Small Cell Lung Cancer
The Evolving Landscape of Targeted Therapies for Non-Small Cell Lung Cancer
Project Oncology®
The Evolving Landscape of Targeted Therapies for Non-Small Cell Lung Cancer
Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
Project Oncology®
Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
Antibody-Drug Conjugates: An Emerging Approach in NSCLC Treatment
Antibody-Drug Conjugates: An Emerging Approach in NSCLC Treatment
Project Oncology®
Antibody-Drug Conjugates: An Emerging Approach in NSCLC Treatment
Staying Up to Date on Advancements in Triple-Negative Breast Cancer Care
Staying Up to Date on Advancements in Triple-Negative Breast Cancer Care
Project Oncology®
Staying Up to Date on Advancements in Triple-Negative Breast Cancer Care
Challenging the Standard of Care in NSCLC: Findings from the TROPION-Lung01 Study
Challenging the Standard of Care in NSCLC: Findings from the TROPION-Lung01 Study
Project Oncology®
Challenging the Standard of Care in NSCLC: Findings from the TROPION-Lung01 Study
When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
Project Oncology®
When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
Pavani Chalasani, MD, MPH; Jose Pablo Leone, MD
- Pavani Chalasani, MD, MPH
- Jose Pablo Leone, MD
The Role of PARP Inhibitors in Metastatic Breast Cancer
The Role of PARP Inhibitors in Metastatic Breast Cancer
Project Oncology®
The Role of PARP Inhibitors in Metastatic Breast Cancer
Approaches to Utilizing Bone-targeting Therapies in mBC
Approaches to Utilizing Bone-targeting Therapies in mBC
Project Oncology®
Approaches to Utilizing Bone-targeting Therapies in mBC
Pavani Chalasani, MD, MPH; Gabriel N. Hortobagyi, MD
- Pavani Chalasani, MD, MPH
- Gabriel N. Hortobagyi, MD
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Project Oncology®
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Pavani Chalasani, MD, MPH; Nick McAndrew, MD, MSCE
- Pavani Chalasani, MD, MPH
- Nick McAndrew, MD, MSCE

32/11